Many protein domains for transcriptional activation also function when fused to a heterologous DMA binding domain. In mammalian HeLa cells, we have previously characterized the activation domains of several transcription factors using GAL4 fusion proteins. Here we have tested their transcriptional activity in oocytes and developing embryos of the clawed toad Xenopus laevis. We find that the "acidic 11 C-terminal domain of the herpesvirus VP16 (= Vmw65) activator, which is active from yeast to man, is also very active in the two Xenopus systems. The constitutive nature of this viral domain may have evolved to be refractory to cellular defense mechanisms. By contrast, activation domains from cellular eukaryotic transcription factors (TFE3, ITF2, MTF-1) are differentially active in oocytes and early embryos. This indicates that their activity can be regulated by protein modification and/or availability of specific coactivators. We have also compared VP16 induced enhancement of transcription from remote and promoter-proximal positions. In both oocytes and late blastula embryos, activation from a promoter-proximal position was more than 50 fold, while only a moderate stimulation (3-8 fold) was observed from remote positions. This may mean that frog oocyte and early embryos are not yet fully geared for gene control by remote enhancers, i.e. respond predominantly to close-by regulatory sequences. The fact that cellular enhancers are naturally located at various distances from the responsive promoters may thus be exploited by multicellular organisms for differential gene control at early and late stages of development.
Introduction
Microinjection into oocytes or fertilized eggs of the african clawed toad Xenopus laevis has long been used to study transcription processes (Mous et al., 1985; Gurdon and Wakefield, 1986 and references therein). In the oocyte, there is generally high transcriptional activity, which attenuates as genes are inactivated upon maturation towards the egg. After fertilization, Xenopus zygotes undergo 12 synchronous rapid divisions which are followed, after a so-called midblastula transition (MBT), by slower and asynchronous cell proliferation. At midblastula transition, RNA polymerases II and III begin to transcribe genes, and cells become motile (Newport and Kirschner, 1982; Kimelman et al, 1987) . Promoters of injected genes are subject to the same timing of expression as the endogenous genes in both amphibian and mouse (Gurdon and Wakefield, 1986; Majumder et al., 1993) .
The function of two classes of c/s-acting transcriptional control elements, namely promoters and enhancers, has been studied in many systems. Enhancer sequences can overlap functionally and physically with the upstream promoter elements, but not every promoter-bound factor is able to function from a distant enhancer position (Seipel et al., 1992) . Thus it seems that the enhancer is not simply an extension of promoter function, but rather has a unique role in transcription. Previously, there have been conflicting reports on enhancer activity in Xenopus oocytes. Simian virus 40 (SV40) genes are expressed when SV40 DMA is injected into the oocyte nucleus (de Robertis and Mertz, 1977; Rungger and Türler, 1987) . Specifically, the SV40 enhancer in its natural viral context was reported to activate the early promoter (Spinelli and Ciliberto, 1985) , while it was inactive in our globin reporter gene constructions (our unpublished data). Other enhancers from Moloney murine sarcoma virus, human c-myc, mouse immunoglobulin, and human a1-antitrypsin genes, had no apparent effect on gene expression in Xenopus oocytes (Spinelli and Ciliberto, 1985; Graves et al., 1985; Nishikura, 1986) , and in mouse oocytes the SV40 enhancer was found to be inactive (Chalifour et al., 1986; .
In this report, we have analyzed transcriptional activation by introducing a defined c/s-control element and the corresponding transcription factors into Xenopus oocytes and embryos. For this we used fusion proteins containing the DMA-binding domain of the yeast transcription factor GAL4 (Brent and Ptashne, 1985) and activation domains of several cellular and viral transcription factors (Seipel et al., 1992) . We found that the activation domain of viral VP16 protein (also referred to as Vmw65, or a-TIF) is ubiquitously active, while three cellular activation domains can have different activities in the oocyte and/or the early embryo, suggesting that they are differentially modified according to their cellular environment, or depend on different coactivators.
We have also studied the long-distance enhancer effect in the oocyte and early embryo. In the mouse, enhancer function was not required for gene expression in oocytes and zygotes (Chalifour et al., 1986; but was utilized from the 2-cell stage of mouse embryos to boost activity of an otherwise weak promoter (Majumder et al., 1993) . However, our data indicate that such a developmental onset of enhancer function may not exist in all animals. Using a well-defined factor in studying the enhancer function in Xenopus oocytes and embryos, we find strong and weak enhancement of transcription by this factor from promoter-proximal and remote positions, respectively. This may mean that remote enhancers play only a moderate role during oocyte/early embryo development in Xenopus.
Results

Different Transactivators have Different Activities in Xenopus Oocytes versus Embryos
Several fusion proteins, which had been shown to activate transcription in mammalian cell lines, were also tested in the Xenopus oocyte and embryo, namely GAL4-VP16(4 χ 11 aa), GAL4-TFE3, GAL4-ITF2, and GAL4-MTFac (Seipel et al., 1992 and unpublished data) . These proteins all contain the DMA-binding domain of yeast transcription factor GAL4 (Brent and Ptashne, 1985) . GAL4-VP16(4x 11 aa) contains 4 copies of the "core" activation sequence of the herpesvirus VP16 (= Vmw65) activation domain. This fusion protein is as active as the protein with the full size 80 aa activation domain (Seipel et al., 1992) . GAL4-TFE3 contains a negatively charged activation domain and GAL4-ITF2 contains a serine-threonine-rich activation domain, derived from helix-loop-helix factors TFE3 and ITF2, respectively, both of which bind to the IgH enhancer The transactivator was either purified recombinant protein, i.e. GAL4(1 -93), GAL4-VP16(40N), or was produced in situ from expression vectors. In these vectors, the CMV enhancer/promoter was driving expression of fusion proteins where the DMA-binding domain GAL4(1 -93) was fused to various activation domains (indicated as "X" on upper right). Reporter gene plasmids contain promoters with 5 GAL4 sites or 1 GAL4 site or an octamer site, either without any enhancer or with 5 GAL4 sites as an enhancer downstream of the -globin gene. All the injection experiments were done by injecting a transactivator with a reporter plasmid and a reference plasmid into the Xenopus oocyte or zygote. (Beckmann et al., 1990; Henthorn et al., 1990) . Lastly, GAL4-MTFac harbors the acidic activation domain of the metallothionein promoter-binding transcription factor 1 (MTF-1) (Radtke etal., 1993) . The transactivator genes under the control of the cytomegalovirus (CMV) promoter/enhancer (Rusconi et al, 1990) were coinjected into Xenopus oocytes together with reporter genes containing 2 GAL4 sites (2G) in the promoter (Figure 1 ). In these experiments, GAL4-VP16(4 11 aa) transactivated best, GAL4-MTFac also gave a considerable amount of transcripts, while GAL4-TFE3 showed only an intermediary activation ( Figure 2A , lanes 1, 4 and 2). GAL4-ITF2, which was highly active in mammalian cells (Seipel etal., 1992 ), gave only a background level of transcription similar to the level of with the GAL4(1 -93) DNA-binding domain alone (Figure 2A , lane 3 and 5). In embryos after the midblastula transition, GAL4-VP16(4x11aa) was again very active, GAL4-TFE3 and GAL4-ITF2 had low activities ( Figure 2B , lanes 1,2 and 3), and GAL4-MTFac was as inactive as GAL4(1 -93) ( Figure  2B , lanes 4 and 5). Using whole-oocyte and embryo extracts, band-shift experiments showed that the fusion proteins were expressed in both the Xenopus oocyte and embryo (data not shown). This implies that the different activities of the factors in the oocytes and embryos are not merely due to different levels of protein expression.
stream of the initiation site (designated 1G), with transcription from an enhancer-containing template (designated 1G/5G, also containing 5 GAL4 binding sites at a remote enhancer position 1.5 kb downstream of the ß-globin gene promoter) ( Figure 3B , lanes 7-10). The enhancer-containing 1G/5G template gave about 3 times more transcripts than 1 G. The enhancer effect was even stronger with "octamer" promoter templates (Oct versus Oct/5G) in A Oocyte f f f f f
Strong and Moderate Stimulation by GAL4-VP16(40N) Protein from Promoter-Proximal and Remote Positions, Respectively, in Xenopus Oocytes
To test for remote activation by an enhancer effect, the Nterminal 40 amino acids of the activation domain from the herpesvirus transactivator VP16 were used. This fusion protein designated GAL4-VP16(40N), containing only a partial activation domain, is more stable than the full domain, yet retains at least 60% activity (Seipel etal., 1992) . We initiated our studies with bacterially expressed and purified GAL4-VP16(40N) protein that was available from another project of ours, but later experiments made predominant use of a GAL4-VP16(40N) gene driven by the CMV enhancer/promoter. Activator protein or activator gene was coinjected into Xenopus oocytes with various templates bearing GAL4 binding sites (Figure 1 ), and the transcripts were quantified by S1 nuclease mapping. Both purified GAL4-VP16(40N) protein and in situ produced GAL4-VP16(40N) can activate transcription from the 5 GAL4 sites promoter (5G) at least 60 fold ( Figure 3A , lanes 3 and 4). By contrast, the mere GAL4 DNA-binding domain GAL4(1-93) (oocyte-expressed or purified protein) had low activity in Xenopus oocytes ( Figure 3A , lanes 2 and 5). Activation by GAL4-VP16(40N) was DNA-binding-dependent, since coinjection of DNA-binding domain GAL4(1-93) strongly repressed the activation by GAL4-VP16(40N) from the 5G promoter by competing for the binding site (Xu etal., 1993) .
We compared the transcriptional activation from a promoter with one GAL4 site located about 40 bp up- The reporter (= test) ß-globin mRNA, harvested from oocytes and stage 12 embryos, was quantified by S1 mapping. The test signal (test) is compared to a reference signal (ref) derived from a coinjected reference plasmid with a shortened ß-globin gene. Transcription stimulated by GAL4-VP16(4 11 aa), GAL4-TFE3, GAL4-ITF2, GAL4-MTFac, driven in oocytes from 2 GAL4 sites (2G) at proximal-promoter position (lanes 1-4 in panel A) are compared with the activity obtained in the embryo (lanes 1 -4 in panel B). As negative control, activity of the DNA-binding domain GAL4(1-93) used for fusion proteins is shown in lanes 5 of panels A and B.
Xenopus oocytes, presumably because transcription from the octamer promoter in absence of the downstream enhancer was quite low ( Figure 3B , lanes 11 -13). To determine the extent of transcriptional activation, the signal from the reporter (test) gene was normalized using the signal from the coinjected reference (re/) gene. However, unlike the transfection experiments in mammalian HeLa cells (Seipel et a/., 1992) , reference gene signals are of limited value in the Xenopus system described here. Ref signals were often reduced by the expression of particular transactivator and/or test genes (see also Xu et a/., 1993) . This effect is probably due to intracellular competition for limiting factors. Accordingly, the most uniform reference gene expression was observed when a given transactivator gene was used in combination with similar test genes ( Figure 3B, lanes 7-12) . However, we also consider the very strong (40-80 fold) activation from the promoterproximal 5 GAL4 sites reliable because it was repeatedly seen even if reference gene expression was not taken into account. The oocyte-expressed GAL4-VP16(40N) protein stimulated transcription from the remote enhancer position more effectively than purified bacterially produced factor, an effect which was not further investigated (data not shown). From the above findings we conclude that an enhancer-active transcription factor can also stimulate transcription from remote positions in the Xenopus oocyte, though to a lesser extent than in HeLa cells (Seipel et al., 1992) .
GAL4-VP16(40N) can also Stimulate Transcription in the Xenopus Embryo after Midblastula Transition
The same templates used in oocytes were also tested in fertilized eggs. Purified GAL4-VP16(40N) was coinjected with DMA templates into fertilized eggs within 45 min after fertilization. The coinjected protein was stable throughout the cleavage division stage, at least until stage 11-12, i.e. about 4 h after the midblastula transition (MBT) (see below). As with the oocytes, transcript levels were determined by RNA mapping. Zygotic transcription is minimal in the frog Xenopus laevis until MBT (Newport and Kirschner, 1982; Kimelman et al., 1987) . Accordingly, we could not detect any transcripts prior to MBT in our experiments (data not shown).
The coinjected protein GAL4-VP16(40N) strongly activated transcription from the 5 GAL4 sites promoter ( 1,2,5,6 ). B) Remote enhancer effect of GAL4-VP16(40N). Reporter template with the 5 GAL4 sites enhancer 1G/5G or Oct/5G (lanes 8,10 and 12) contains 1 GAL4 site or an octamer site at the same proximal position as in templates 1G or Oct (lanes 7,9 and 11). The reporter templates tested in lanes 7 and 8 have the same promoter/coding-region/enhancer as the templates tested in lanes 9 and 10, respectively, except for the flanking sequences in the vector. Lane 13 is a control for the basal transcription level from an Oct/5G template without injected transactivator. When the DMA template of the GAL4-VP16(40N) gene driven by the CMV promoter/enhancer was coinjected with the reporter gene into fertilized eggs, the activator was expressed in the embryos, presumably with an onset after midblastula transition, and also strongly activated transcription of the reporter gene from the 5G promoter ( Figure 4A, lane 3) . When either the GAL4-VP16(40N) protein or the gene coding for it were coinjected with 1G or 1G/5G template, more transcripts were made from the 1G/5G template (containing the 5 GAL4 binding sites at the downstream enhancer position), in comparison to 1G template (only one GAL4 site at the promoter position) ( Figure 4B , lanes 5 and 6,9 and 10). As in the oocyte, the combination octamer promoter/5G enhancer was most obviously activated (8 fold; Figure 4B , lanes 7 and 8,11 and 12). Interestingly, purified GAL4-VP16(40N) protein injected into the egg obviously persisted through midblastula transition and was as active for remote activation as the embryo-expressed factor ( Figure 4A , lanes 2 and 3). We conclude that in fertilized eggs after midblastula transition, like in oocytes, theVP16 domain could stimulate transcription to high and intermediate levels from close-by and remote positions, respectively.
Discussion
Constitutive Viral versus Regulated Cellular Activation Domains?
In our experiments in the Xenopus system, we have tested several GAL4 fusion proteins which previously had been shown to be highly active in cultured epithelial (HeLa) cells (Seipel et al., 1992) . While two constructs with the viral VP16 activation domain (GAL4-VP16(40N) and GAL4-VP16(4 χ 11 aa)) are highly active both in oocytes and embryos, the cellular activation domains of GAL4-MTFac, GAL4-TFE3 and GAL4-ITF2 show a pattern of differential activities. The activity of a transcription factor can be hampered, for example, by the association with a repressing factor or lack of a coactivator, perhaps similar to the yeast GAL4/ GAL80 and GAL4/GAL11 interactions, respectively (Ma and Ptashne, 1987; Nishizawa etal., 1990; Suzuki et al., 1992) . Recently, it has become evident that an activation domain itself can have conditional activity, notably as a result of phosphorylation-dephosphorylation. Such a regulation was found for c-Jun (Binotruy etal., 1991; Pulverer ef a/.; Smeal ef a/., 1991; Hunterand Karin, 1992) and also for an ets-type factor which is involved in serum response (Marais etal., 1993; Janknecht etal., 1993) .There-fore, we conclude that the ubiquitously active viral VP16 contains a fail-safe constitutive activation domain, perhaps to escape down-regulation by any cellular defense mechanism. Cellular activation domains, by contrast, can obviously be subject to a more complex regulation.
Weak but Significant Enhancer Activity in Xenopus Oocytes and Embryos
The fusion protein GAL4-VP16(40N) used in our analysis was previously shown to be highly active in vivo in HeLa cells (Seipel et al., 1992) . In Xenopus oocytes, GAL4-VP16(40N) showed high and low activity from promoter and enhancer positions, respectively. This establishes that the Xenopus oocyte has at least a moderate potential for activation by a remote enhancer. Previously, several enhancers containing multiple functional motifs were reported to be inactive in the Xenopus oocyte (Spinelli and Ciliberto, 1985; Graves etal., 1985; Nishikura, 1986) . This inactivity might have been due to the lack of specific transcription factors in the oocyte, and/or inactivity of their activation domains. The second possibility is supported by the experiments presented in Figure 2 , where a factor (e.g. GAL4-ITF2) that is very active in HeLa cells shows low activity in the oocyte.
Our data show that remote enhancer activity was similar in oocytes and after midblastula transition in Xenopus embryos, while in mouse embryos efficient enhancer activity was observed as early as the 2-cell stage but not in oocytes and zygotes (Majumder et al., 1993) . Xenopus eggs complete 12 rounds of cleavage in only 25% of the time it takes mouse eggs to complete the first mitosis. Thus it may not be surprising that early transcription events are not regulated the same way in the two species.
Is a Chromatin Structure Required for the Enhancer Effect?
It has been postulated that an enhancer facilitates DMAbinding of factors at the promoter by "opening" the chromatin structure, perhaps by counteracting the effect of H1 histone (Croston et al., 1991; Laybourn and Kadonaga, 1991; Croston etal., 1992) .This concept is supported by experiments of Laybourn and Kadonaga (1992) who found a threshold effect on long distance activation by GAL4-VP16 in the presence of stochiometric amounts of H1 in in vitro transcription experiments.
However, the concept of long-range activation being dependent on H1 histone is at variance with a report of remote transcription activation in vitro (Carey et al., 1989) , and by the observation of upstream enhancer effects in yeast, which lack H1, and even in bacteria (Ptashne, 1986; Künzler etal., 1994; Magasanik, 1989) . In these latter systems, enhancement is usually observed over a few hundred basepairs only, and to our knowledge there has been no systematic study to quantify distance effects in vivo in yeast. Certain chromatin structures may facilitate a functional interaction of enhancer and promoter by merely reducing the distance between them. Compatible with this idea is our finding that the SV40 enhancer was able to activate a promoter in vitro to which it was linked noncovalently via a protein bridge (Müller etal., 1989) .
While the Xenopus oocyte acquires a huge store of core histones during differentiation within the ovary (Smith et al., 1988; Laskey and Leno, 1990) , the oocyte lacks H1 histone and instead contains a H1-like protein designated B4. Injected DNA is readily packaged into a bona fide nucleosome structure (Laskey et al., 1977) . Accordingly, when we injected DNA template into the Xenopus oocyte, it was first relaxed and then organized into a chromatin structure within 120 min, as measured by supercoil density (data not shown). Chromatin formation prior to the injection of transcription factor did not alter the transcriptional response: When we separately injected the factor 3 hours later than the reporter template, we observed a similar level of transcription to that in coinjection experiments (our unpublished data; see also Xu et al., 1993) . So far, however, we do not know whether organization of chromatin is necessary for the transcription effects observed. In early Xenopus embryos, histone H1 gradually replaces the B4 protein after the MBT. The fact that we find about the same weak but significant enhancer effect in both oocytes and embryos would indicate that the contribution of proteins B4 and H1 to transcriptional activation from a distance, if any, is the same.
Differential Gene Control by Enhancer Distance
In our experiments in frog oocytes and embryos, the same activator protein worked well from a promoter-proximal position but only weakly from a remote position. We cannot exclude that the ß-globin locus contains some sequence element that inhibits activation by the remote 5 GAL4 enhancer in Xenopus oocytes and embryos but not mammalian cells. However, we consider it more likely that frog oocytes and embryos can only effectively use closeby enhancers. Indeed, a construct where the 5 GAL4 enhancer was inserted 800 bp upstream from the promoter also had a relatively low activity, yet higher than our standard enhancer insertion 1.5 kb downstream from the promoter (data not shown). This indicates that distance was the main determinant. The many cellular enhancers known are located at various distances from the responsive promoters. Therefore, enhancer distance may be exploited for differential gene control at earlier and later ontogenic stages. Thus one may speculate that early embryonic genes rely mostly on proximal c/s-regulatory control sequences, while genes of later developmental stages and differentiated cells could be activated over great distances. Examples of the former and latter may be the housekeeping genes, which are usually transcribed from so-called CpG island promoters (Bird, 1986; GardinerGarden and Frommer, 1987; Matsuo etal., 1993) , and immunoglobulin genes which are activated by remote enhancers that have been found both inside as well as 25 kb downstream of the locus (Banerji etal., 1983; Gillies etal., 1983; Pettersson etal., 1990) .
Materials and Methods
Construction of Plasmids
The fusion protein expression vectors containing a CMV promoter were constructed as described in Seipel et ai (1992) . The same coding sequence was cloned into an E. co//expression vector described elsewhere (Rigoni, 1992) . GAL4(1-93) and GAL4-VP16(40N) proteins for coinjection studies were overexpressed in E co//and purified over Bio-Rex 70 ion-exchange column (Rigoni, 1992) . The constructs bearing GAL4 binding sites, either in a promoter or in an enhancer position, were prepared as described in Seipel etal. (1992) . Each GAL4 site contained two palindromic GAL4 binding sequences. The ref2 and CMV-ref constructs were kind gifts from Dr. Sandro Rusconi.
Oocyte Injection (Rungger eta/., 1990)
Xenopus laevis females, purchased from the African Xenopus Facility (Noordhoek, Republic of South Africa) were kept at 23°C in tanks with a circulating supply of water (low calcium, low chlorine). The animals were fed granulated trout food twice a week and the water was changed entirely on the following day. The females were anaesthesized in 1 % MS222 (3-aminobenzoic acid ethyl ester, Sigma) and sacrificed by decapitation. The ovary was cut into fine pieces, and oocytes were freed from their follicle by digestion in 0.2% collagenase in OR2 (82.5 mM NaCI, 2.5 ΓΤΙΜ KCI, 1 mM Na2HPO4, 5mM Hepes, 0.5mM PVP) (Wallace etal., 1973) solution without calcium for 2-3 h at room temperature. Centrifugation of the oocytes (400 χ g, 10 min, 19 °C), in 6 cm plastic petri dishes with 0.8-mm-mesh plastic grids (Z rcher Beuteltuchfabrik, R schlikon, Switzerland) glued to the bottom with a few drops of CHCI 3> brings the nuclei towards the surface where their position was marked by a white area in the pigmented animal hemisphere (Kressmann etal., 1977) . A simple micromanipulator (Singer Instrument Co., Roadwater Somerset, GB) with a 4:1 gear permited rapid injection. The injection volume was controlled with an automatic pressure generator, inject + Matic (Gabay, Geneva). The genes and protein mixtures (5 ng in 10 nl of DMA injection buffer: 89mM NaCI, 1 mM KCI, 20mM Hepes, pH 7) were injected into the nucleus (germinal vesicle). Following injections, the oocytes were incubated for 15 to 20 h in OR2 solution containing antibiotics (50 iU of penicillin and 50 jig/ml of streptomycin, and 20 μg/ml of kanamycin).
Preparation of Embryos (Thiebaud etal., 1984)
To procure eggs, a female was injected subcutaneously with mammalian gonadotropic hormone, obtainable commercially (50 units and 350 units 4 h later). Eggs were striped from the females directly into dry Petri dishes. The male was sacrificed, and the testes were minced and resuspended in Ringer buffer (113 mM NaCI, 2mM KCI, 0.7 mM CaCI 2 ,2.4 mM NaHCO 3 , pH 7.8) to 3 χ 10 7 spermatids/ml (In this buffer, sperm remains immotile and may be kept for several hours). For fertilization, the eggs were incubated with 2 drops of sperm suspension and 6 drops of H 2 O for 15 min at room temperature (20 °C). The eggs of Xenopus are covered with a sticky jelly. After fertilization eggs were dejellied in 3% cysteine (neutralized to pH 7.8 with NaOH) for 7 min at room temperature. Injections were carried out within 15 min and one hour after fertilization, well before the first division which occurs after about 2 h. Fertilized eggs are more fragile than oocytes. Zygotes cannot survive an injection of DMA that exceeds 250 pg (Rusconi and Schaffner, 1981) . A typical injection mix contains 100 pg target DNA, 50 pg reference gene and 100 pg transactivator-coding DNA. For protein coinjection, the mixtures contain 200 pg target DNA, 50 pg reference gene and 1 ng purified protein. After injections, the embryos were incubated in OR2 buffer + calcium until the 4 cell-stage and then the buffer was diluted by 1 volume of aged H 2 O. Following the morula stage, the embryos were incubated in aged H 2 O + antibiotics. The developmental stages of embryos were determined according to Nieuwkoop and Faber (Nieuwkoop and Faber, 1967) .
RNA Extraction
Batches of 10 healthy oocytes or embryos were homogenized in 500 μΐ lysis buffer (50mM NaCI, 50mMTris-CI pH 7.5, 5mM EDTA, 0.5% SDS + 1 mg/ml proteinase K) and incubated for 45 min at room temperature (Probst etal., 1979) . RNA was extracted with phenol/DCM and DCM or chloroform/isoamylalcohol. The amount of RNA equivalent to 2 oocytes or embryos was co-precipitated with radioactive probe in EtOH for S1 mapping. Before analysis the yield of RNA was measured by Λ 260 .
S1 Nuclease Protection Assay (Westin etal., 1987)
All test plasmids and reference genes used contained the widely used rabbit -globin coding sequence. A DNA oligonucleotide covering -18 to +75 of the -globin gene was synthesized and end-labeled with [ The test signals were normalized according to the reference transcripts and quantitated by phosphor-imager.
